MedTrace Logo

ProbioKid as Prevention Among Kids With Frequent URTI

NCT04525040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2020-08-25

No results posted yet for this study

Summary

This study was designed to evaluate the preventive efficacy of a 6-week prophylactic administration of Probiokid® on the incidence of respiratory infections and related complications in frequently sick children.

Conditions

  • Respiratory Tract Infections

Interventions

DIETARY_SUPPLEMENT

ProbioKid®

Probiokid formulation includes three probiotic strains and fructooligosaccharides.

OTHER

Pragmatic comparator

Standard of care as usual without a preventive intervention

Sponsors & Collaborators

  • Lallemand Health Solutions

    lead INDUSTRY

Principal Investigators

  • Yu V. Marushko, MD · Bogomolets National Medical University (Kiev, Ukraine)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-14
Primary Completion
2017-06-25
Completion
2017-06-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04525040 on ClinicalTrials.gov